The global plasma therapy market is expected to grow with the CAGR of 12%-16% by 2025

   January 13, 2021
According to a new market report published by Lucintel, the future of the plasma therapy market looks promising with opportunities in applications, like orthopedics, dermatology, dental, cardiac mucle injury, and nerve injury. The global plasma therapy market is expected to grow with a CAGR of 12%-16% from 2020 to 2025. The major drivers for this market are increasing incidence of sports injuries, arthritis, and growing use of platelet-rich plasma in various therapeutic areas.  

The plasma therapy is the process of healing wounds, androgenetic alopecia, and face rejuvenation through blood plasma that comprises of platelets, autologous platelets and cytokines which arouse healing of soft tissues. In this market, pure PRP, leucocyte-rich PRP, pure platelet-rich fibrin, and leukocyte-rich fibrin are the major types. Lucintel forecasts that pure PRP will remain the largest type segment over the forecast period due to effective results of pure PRP.

Within this market, hospitals and clinics will remain the largest end user segment over the forecast period due to an increase in healthcare expenditure and rise in the use of PRP products in hospitals.

North America will remain the largest region over the forecast period due to increasing awareness of plasma therapy and its acceptance as a suitable remedy for healing of bones and other tissues.

BioLife Plasma, Cambryn Biologics, Biotest, CSL, Grifols, Kedrion, LFB, Bio Products Laboratory, China Biologic Products, and Octapharma are among the major suppliers in the global plasma therapy market.

Lucintel, a leading global strategic consulting and market research firm, has analyzed growth opportunities in the global plasma therapy market by type, source, application, end user, and region. Lucintel has prepared a comprehensive research report titled “Growth Opportunities in the Global Plasma Therapy Market 2020-2025: Trends, Forecast, and Opportunity Analysis.” This Lucintel report serves as a catalyst for growth strategy, as it provides comprehensive data and analysis on trends, key drivers, and directions. The study includes trends and forecast for the global plasma therapy market by type, source, application, end user, and region as follows:

By Type [Value ($ Million) shipment analysis for 2014 – 2025]:

  • Pure PRP (Platelet-Rich Plasma)

  • Leucocyte-Rich PRP

  • Pure Platelet-Rich Fibrin (PRF)

  • Leukocyte-Rich Fibrin (L-PRF)


By Source [Value ($ Million) shipment analysis for 2014 – 2025]:

  • Autologous

  • Allogenic

By Application [Value ($ Million) shipment analysis for 2014 – 2025]:

  • Orthopedics

  • Dermatology

  • Dental

  • Cardiac Muscle Injury

  • Nerve Injury

  • Others

By End User [Value ($ Million) shipment analysis for 2014 – 2025]:

  • Hospitals & Clinics

  • Research Institutions

By Region [Value ($ Million) shipment analysis for 2014 – 2025]:

  • North America

  • United States

  • Canada

  • Mexico

  • Europe

  • United Kingdom

  • Spain

  • Germany

  • France

  • Asia Pacific

  • China

  • India

  • Japan

  • The Rest of the World

  • Brazil

This more than 150-page research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or visit us at

About Lucintel

Lucintel, the premier global Management Consulting and market research firm, creates winning strategies for growth. It offers market assessments, competitive analysis, opportunity analysis, Growth Consulting, M&A, and Due diligence services to executives and key decision makers in a variety of industries. For further information, visit

Lucintel Corporate Customers

Market Entry, M & A, Opportunity Screening,...

Private Equity Customers

Buy Side Services (target screening, due diligence, ..)

Customer Quotes

"With more than 20 years experience in the industry, this is the first time we have come across such an extensive market analysis for our industry." Ven Cote, CEO, ZCL

"The insights we gained from Lucintel work helped with our business plan…a wonderful professional job…" Mike Jackson, Stahlin

"The report from Lucintel is useful not only for business planners, but also for the technology officers wanting to create a roadmap …" Dr. Giulio Ranzo, Booz Allen

"The information is so comprehensive, it has allowed us to identify & focus our business development efforts. It saved months of leg-work." Bill Barz, L&L Products

"We bought Lucintel report because it is the best report about our industry…a complete and appropriate analysis." Cesare Andrenacci, Ferretti